news Cilcare wins prestigious Hearing Technology Innovator Award for CIL001 Learn More > 25 September 2024 Cilcare Awarded €4.2 million to combat the global epidemic of hidden hearing loss, as part of the France 2030 Plan’s “i-Démo” call for projects Learn More > 27 June 2024 Cilcare and Shionogi announce exclusive Option Agreement for innovative hearing disorder treatment Learn More > 6 June 2024 Cilcare appoints Naimi Missoum as Chief Medical Officer Learn More > 23 May 2024 Cilcare-CBSET’s review article on ototoxicity published in Frontiers in Molecular Neuroscience ! Learn More > 21 May 2024 Cilcare featured in NewScientist ! Learn More > 30 April 2024 Cilcare presenting at the 4th annual Future of Hearing Healthcare conference ! Learn More > 20 April 2024 Cilcare expands its collaboration network to accelerate revolutionary treatment for cochlear synaptopathy with new clinical trial and biomarker innovation Learn More > 18 April 2024 Cilcare and its partner CBSET to present at the next SPS 2024 Northeast Regional Meeting Learn More > 4 April 2024 « Previous Page1 Page2 Page3 Page4 … Page25 Next »
Cilcare wins prestigious Hearing Technology Innovator Award for CIL001 Learn More > 25 September 2024
Cilcare Awarded €4.2 million to combat the global epidemic of hidden hearing loss, as part of the France 2030 Plan’s “i-Démo” call for projects Learn More > 27 June 2024
Cilcare and Shionogi announce exclusive Option Agreement for innovative hearing disorder treatment Learn More > 6 June 2024
Cilcare-CBSET’s review article on ototoxicity published in Frontiers in Molecular Neuroscience ! Learn More > 21 May 2024
Cilcare presenting at the 4th annual Future of Hearing Healthcare conference ! Learn More > 20 April 2024
Cilcare expands its collaboration network to accelerate revolutionary treatment for cochlear synaptopathy with new clinical trial and biomarker innovation Learn More > 18 April 2024
Cilcare and its partner CBSET to present at the next SPS 2024 Northeast Regional Meeting Learn More > 4 April 2024
